Hikma SmartDose Pro inhaler launches as connected relief for busy asthma patients
16.06.2026 - 18:48:38 | ad-hoc-news.de
By John Doe, ad-hoc-news, June 15, 2026
Hikma SmartDose Pro inhaler targets asthma patients who are tired of guessing when their rescue inhaler will run out and whether they are really taking each dose correctly. The compact connected device combines precise metering with discreet app integration for everyday use.
Hikma expands respiratory portfolio for chronic care patients
Further coverage of Hikma's current strategy and product pipeline for long term investors.
New release aims to remove guesswork from daily asthma control
If you live with asthma, you already juggle triggers, schedules, and the constant worry of a sudden flare up. What often slips through the cracks is simple: knowing how many doses are left in your inhaler and whether each puff is delivered correctly.
Hikma SmartDose Pro tackles that stress with a built in dose counter, audio and haptic feedback, and optional Bluetooth syncing. The device records every actuation and can gently nudge you through your smartphone when it detects gaps in your routine.
Compact design with app support for real life use
The inhaler keeps a familiar press and breathe experience, so you do not have to relearn your technique. A slim profile fits easily in a jeans pocket or small handbag, while a textured grip helps you keep control during rushed moments on a crowded train or busy street.
Paired with the companion app, SmartDose Pro lets you review recent usage patterns without digging through charts or text heavy logs. A clean timeline shows when you reached for relief and how many puffs you used, which you can later discuss with your physician.
Hikma and market context for respiratory care investors
Generic drug manufacturer Hikma Pharmaceuticals PLC, ticker LSE:HIK, ISIN GB00B128J450, continues to expand its branded and specialty respiratory offerings in competitive markets. The company positions SmartDose Pro as a bridge between traditional metered dose inhalers and fully integrated digital health platforms.
For investors following chronic care trends, connected inhalers form part of a broader push toward patient centric devices. These products aim to improve adherence and outcomes while generating data that can support value based care negotiations with payers and health systems.
Hikma SmartDose Pro inhaler at a glance
Name: Hikma SmartDose Pro inhaler
Manufacturer: Hikma Pharmaceuticals PLC
Category: Connected asthma inhaler, new release
Key features: Digital dose counter, audio and haptic feedback, Bluetooth connectivity, companion app support, compact pocket friendly design
Price: 49.99 EUR
Availability: In stock via selected online pharmacies and retail platforms
Buy Hikma SmartDose Pro inhaler
For patients who prefer online ordering, SmartDose Pro is also listed through selected Amazon sellers, subject to regional availability and prescription rules.
Affiliate link - we may earn a commission at no extra cost to you.
Share this article
This article contains affiliate links. If you click on an Amazon link and make a purchase, ad-hoc-news may receive a commission. Editorial coverage, assessments, and pricing information remain independent of this potential compensation.
